Akebia Therapeutics, Inc. Appoints Jason A. Amello as Senior Vice President, Chief Financial Officer and Treasurer
Akebia Therapeutics, a leader in the development of hypoxia-inducible factor (HIF) inhibitors as therapeutic advances for patients with serious diseases, today announced that it has appointed Jason A. Amello as Senior Vice President, Chief Financial Officer and Treasurer. Mr. Amello previously served as Executive Vice President, CFO and Treasurer of ZIOPHARM Oncology and as Senior Vice President, Corporate Controller and Chief Accounting Officer of Genzyme Corporation.
Help employers find you! Check out all the jobs and post your resume.